Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020

SARS SARS-CoV-2 Denmark R COVID-19 Infectious and parasitic diseases RC109-216 Antibodies, Viral 3. Good health respiratory infections 03 medical and health sciences 0302 clinical medicine coronavirus disease Seroepidemiologic Studies Research Letter Prevalence Medicine Humans severe acute respiratory syndrome coronavirus 2
DOI: 10.3201/eid2801.210917 Publication Date: 2021-11-10T14:29:14Z
ABSTRACT
We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (10)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....